2110 Vaginal CO2 Laser as Minimal Non-Invasive Treatment for Urinary Stresss Incontinence

M Alcalay,A Greenshpun,M Ben Ami,E Schiff
DOI: https://doi.org/10.1016/j.jmig.2019.09.429
IF: 4.314
2019-11-01
Journal of Minimally Invasive Gynecology
Abstract:Study Objective To assess the efficacy of vaginal CO2 laser in women with urodynamic stress incontinence (USI) that were followed for one year. Design Prospective multicenter study. Following laser treatments, the patients were followed for 3, 6 and 12 months. Setting University affiliated hospitals Patients or Participants Patients with USI that were graded as mild or moderate were allowed to participate. We recruited 32 patients with USI, of whom 29 completed follow-up for 12 months. Interventions Every patient had three sessions of CO2 laser, 4-5 weeks apart. Measurements and Main Results We used 1-hour pad test (ICS protocol), stress test, questionnaires (PFDI-20, PFIQ, Patient Global Impression of Improvement (PGI-I)) and a 3-day urinary diary at each follow-up visit. Second urodynamic test was performed at 6 months follow-up. No serious adverse events were recorded. Minor side effects that were related to treatment included: transient vaginal secretion (4 patients), vaginal irritation (1 patients), transient fever (1 patient), and UTI (1 patient). The patients’ 1 hour pad test showed significant decrease from 2 months FU and onward. Pad test and PGI-I showed time - dependency. 68.9% (20 of 29) of the patients felt improvement (PGI-I) at 12 month following the treatment, of whom 11 (37.9%) described it as “very significant” or “significant” and 9 (31%) “some” improvement. Patient's bladder symptoms (PFDI) improved significantly between 1 to 6 months and accordingly quality of life (PFIQ) improved significantly. At 6 months - stress test with full bladder was negative in 68%, however, urodynamic assessment was negative for stress incontinence only in 38.7%. Conclusion Vaginal CO2 laser was found a safe non-invasive treatment for patients with urodynamic proven stress incontinence. Significant subjective improvement was time dependent and 68.9% reported improvement at 12-month follow-up. The objective urodynamic cure was 38.7%. The short-term efficacy is promising, however, long term follow-up and optimizing treatment protocol are needed.
obstetrics & gynecology
What problem does this paper attempt to address?